Dr. Guillaume Marquis-Gravel, MD
Claim this profileMontreal Heart Institute
Studies Myocardial Infarction
Studies Myocardial Infarction or Heart Attack
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Guillaume Marquis-Gravel, MD is currently running
Personalized Hydration Strategy
for Acute Kidney Injury
The NEPTUNE triple-blind, active-placebo, adaptive, pragmatic, randomized trial aims to evaluate the effectiveness of a new intra-venous hydration strategy guided by left ventricular end-diastolic pressure (LVEDP), amount of contrast used, and baseline renal function, to prevent contrast-induced acute kidney injury (CI-AKI) and patient-oriented clinical endpoints in all-comer patients undergoing coronary angiogram and/or percutaneous coronary intervention (PCI).
Recruiting1 award N/A4 criteria
Aspirin Dosing
for Type 2 Diabetes
This phase 2 study will include patients suffering from type 2 diabetes mellitus and will first study their response to enteric coated aspirin at a dose of 80 mg per day for a 7-day period. Participants with an incomplete platelet inhibition after exposure to EC aspirin at doses of 80 mg once daily will be randomized to a random order of 3 different ASA regimens: EC ASA 162 mg once daily, EC ASA 81 mg twice daily and chewable ASA 40 mg twice daily. The aims are to determine the feasibility of a larger scale trial, and to determine the regimen associated with the lowest proportion of non-responders after randomization. Platelet function will be assessed at baseline and at day 7 of each arms of the study.
Recruiting1 award Phase 14 criteria
More about Guillaume Marquis-Gravel, MD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Guillaume Marquis-Gravel, MD has experience with
- IMPELLA® CP System
- Personalized Hydration Strategy
- Standard Of Care
- Aspirin
Breakdown of trials Guillaume Marquis-Gravel, MD has run
Myocardial Infarction
Myocardial Infarction or Heart Attack
Heart Attack
Acute Kidney Injury
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Guillaume Marquis-Gravel, MD specialize in?
Guillaume Marquis-Gravel, MD focuses on Myocardial Infarction and Myocardial Infarction or Heart Attack. In particular, much of their work with Myocardial Infarction has involved treating patients, or patients who are undergoing treatment.
Is Guillaume Marquis-Gravel, MD currently recruiting for clinical trials?
Yes, Guillaume Marquis-Gravel, MD is currently recruiting for 3 clinical trials in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Guillaume Marquis-Gravel, MD has studied deeply?
Yes, Guillaume Marquis-Gravel, MD has studied treatments such as IMPELLA® CP System, Personalized hydration strategy, Standard of care.
What is the best way to schedule an appointment with Guillaume Marquis-Gravel, MD?
Apply for one of the trials that Guillaume Marquis-Gravel, MD is conducting.
What is the office address of Guillaume Marquis-Gravel, MD?
The office of Guillaume Marquis-Gravel, MD is located at: Montreal Heart Institute, Montreal, Quebec H1T 1C8 Canada. This is the address for their practice at the Montreal Heart Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.